Search | Aplastic Anemia and MDS International Foundation


Search results

  1. Daclizumab

    ... of organ rejection. Currently, researchers are studying daclizumab for treating aplastic anemia to determine whether it ...

    Drug last updated 03/26/2016 - 8:14pm.

  2. Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab.

    ... and pure red cell aplasia (PRCA) patients with daclizumab , a humanized monoclonal antibody to the interleukin-2 ... events were transient rashes and arthralgias. Daclizumab is safe and effective, and produces lengthy remissions in patients ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. Recent Developments in Drug Therapy for Aplastic Anemia

    ... with hATG fails or when hATG is unavailable. Front-line daclizumab can be considered for nonsevere AA (NAA); however, data is ... rATG is reserved for salvage therapy. Front-line use of daclizumab has been studied in NAA patients, but additional prospective trials ...

    Research Article last updated 09/24/2014 - 10:21am.

  4. Antibodies in the treatment of aplastic anemia.

    ... have emerged: porcine ATG, alemtuzumab , daclizumab , and rituximab. Experience with these antibodies is limited to a ...

    Research Article last updated 06/15/2012 - 3:06pm.

  5. Drugs

    ... C ytoxan daclizumab Z enapax ...

    Page last updated 03/02/2016 - 9:11am.